| Literature DB >> 28979140 |
Wenjie Chen1, Jianyong Lei1, Jiaying You2, Yali Lei3, Zhihui Li1, Rixiang Gong1, Huairong Tang3, Jingqiang Zhu1.
Abstract
BACKGROUND: Recurrent laryngeal nerve (RLN) invasion in papillary thyroid carcinoma (PTC) is one of the main predictors of poor prognosis. The present study investigated the risk factors for RLN invasion in PTC patients.Entities:
Keywords: Hashimoto’s thyroiditis; lymph node metastases; papillary thyroid carcinoma; predictive factors; recurrent laryngeal nerve invasion
Year: 2017 PMID: 28979140 PMCID: PMC5602280 DOI: 10.2147/OTT.S142799
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
Associations between clinicopathological characteristics and PTC patients with or without RLN invasion
| Preoperative features | Invasion group | Control group | Univariate |
|---|---|---|---|
| Age (y) | 50.4±13.8 | 42.3±12.1 | < |
| ≤45 | 35 | 1,919 | |
| >45 | 70 | 1,212 | < |
| Sex | |||
| Male | 38 | 1,006 | |
| Female | 67 | 2,125 | 0.381 |
| Height (cm) | 162.3±7.1 | 163.6±7.7 | 0.098 |
| Weight (kg) | 63.0±11.5 | 63.0±12.4 | 0.972 |
| BMI (kg/m2) | 24.0±3.4 | 23.5±4.90 | 0.314 |
| Unilateral multifocality | |||
| No | 90 | 2,595 | |
| Yes | 15 | 536 | 0.511 |
| Bilaterality | |||
| No | 72 | 2,327 | |
| Yes | 33 | 804 | 0.186 |
| PTC variant | |||
| Follicular | 0 | 17 | |
| Conventional | 105 | 3,114 | 0.449 |
| Largest tumor size (mm) | 26.0±12.4 | 12.4±7.5 | < |
| ≤10 | 13 | 1,662 | |
| >10 | 92 | 1,469 | < |
| N stage | |||
| cN0 | 45 | 2,790 | |
| cN1 | 60 | 341 | < |
| Tumor longitudinal location | |||
| Superior | 23 | 562 | |
| Median | 49 | 1,223 | |
| Inferior | 30 | 1,286 | |
| Isthmic | 3 | 60 | 0.072 |
| Tumor sagittal location | |||
| Anterior | 52 | 2,457 | |
| Posterior | 53 | 674 | < |
| Extrathyroidal extension | |||
| No | 2 | 1,639 | |
| Yes | 103 | 1,492 | < |
| Esophageal extension | |||
| No | 75 | 3,070 | |
| Yes | 30 | 61 | < |
| Tracheal extension | |||
| No | 54 | 3,031 | |
| Yes | 51 | 100 | < |
| NG | |||
| No | 44 | 1,490 | |
| Yes | 61 | 1,641 | 0.251 |
| HT | |||
| No | 90 | 2,049 | |
| Yes | 15 | 1,082 | < |
| Pre-vocal cord paralysis | |||
| No | 77 | 3,130 | |
| Yes | 28 | 1 | < |
| Pre-hoarseness | |||
| No | 97 | 3,130 | |
| Yes | 8 | 1 | < |
Note: Bold figures indicate p<0.05 which were considered statistically significant.
Abbreviations: RLN, Recurrent laryngeal nerve; PTC, Papillary thyroid carcinoma; BMI, body mass index; cN, clinical lymph node metastasis; NG, nodular goiter; HT, Hashimoto’s thyroiditis; Pre-vocal cord paralysis, preoperative vocal cord paralysis; Pre-hoarseness, preoperative hoarseness.
Multivariate Logistic Regression for risk factors for RLN invasion in PTC
| Preoperative features | OR | 95% confidence interval | |
|---|---|---|---|
| Age (y) | < | ||
| ≤45 | Ref | ||
| >45 | 4.958 | 2.572–9.557 | |
| Largest tumor size (mm) | < | ||
| ≤10 | Ref | ||
| >10 | 15.853 | 6.595–38.105 | |
| N stage | < | ||
| cN0 | Ref | ||
| cN1 | 12.520 | 6.191–25.321 | |
| Tumor sagittal location | < | ||
| Anterior | Ref | ||
| Posterior | 5.328 | 2.618–10.840 | |
| Extrathyroidal extension | < | ||
| No | Ref | ||
| Yes | 97.662 | 11.882–802.731 | |
| Esophageal extension | < | ||
| No | Ref | ||
| Yes | 7.381 | 2.967–18.362 | |
| Tracheal extension | < | ||
| No | Ref | ||
| Yes | 25.885 | 11.833–56.626 | |
| HT | 0.098 | ||
| No | Ref | ||
| Yes | 0.442 | 0.169–1.161 | |
| Pre-vocal cord paralysis | < | ||
| No | Ref | ||
| Yes | 1,600.100 | 122.030–20,981.050 | |
| Pre-hoarseness | 0.770 | ||
| No | Ref | ||
| Yes | 0.560 | 0.012–27.232 |
Note: Bold figures indicate p<0.05 which were considered statistically significant.
Abbreviations: RLN, Recurrent laryngeal nerve; PTC, Papillary thyroid carcinoma; OR, odds ratio; cN, clinical lymph node metastasis; HT, Hashimoto’s thyroiditis; Pre-vocal cord paralysis, preoperative vocal cord paralysis; Pre-hoarseness, preoperative hoarseness; Ref, reference.
Postoperative complications and recovery of the two patient groups
| Complications | Invasion group (n=105) | Control group (n=3,131) | |
|---|---|---|---|
| Postoperative hospital stay (days) | 9.3±9.6 | 5.6±2.4 | < |
| Postoperative drainage volume | 450.4±429.1 | 384.0±249.1 | 0.116 |
| Overall hospitalization costs (dollar) | 4,012.8±1,839.8 | 3,496.8±756.7 | |
| Autologous parathyroid transplantation (yes) | 82 (78.1%) | 2,629 (84.0%) | 0.108 |
| Temporary hypocalcemia | 68 (64.8%) | 2,164 (69.1%) | 0.343 |
| Permanent hypocalcemia | 4 (3.8%) | 58 (1.9%) | 0.281 |
| Bleeding | 0 (0%) | 6 (0.2%) | 0.653 |
| Chyle leakage | 2 (1.9%) | 43 (1.4%) | 0.973 |
| Esophageal fistula | 0 (0%) | 3 (0.1%) | 0.751 |
| Tracheal fistula | 1 (0.95%) | 5 (0.2%) | 0.063 |
| Infection | 1 (0.95%) | 13 (0.4%) | 0.409 |
Note: Bold figures indicate p<0.05 which were considered statistically significant.
Figure 1The graph shows the predictive recurrence-free survival (RFS) in invasion group and control group.
Note: The difference between the two groups was significant (p<0.001).
Surgical management of invasion group and the situation of recurrence in different subgroups
| Partial layer resection | Resection or reconstruction | |
|---|---|---|
| Recurrence | 15 | 7 |
| Nonrecurrence | 52 | 31 |
Figure 2The graph shows the predictive recurrence-free survival (RFS) in different surgical method subgroups of invasion group.
Note: No significant difference was found between partial layer resection group and resection or reconstruction group (p=0.743).